MIV 150
CAS No. 231957-54-3
MIV 150 ( PC-815;MIV150 )
Catalog No. M13656 CAS No. 231957-54-3
A high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1323 | Get Quote |
|
50MG | 2682 | Get Quote |
|
100MG | 3600 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMIV 150
-
NoteResearch use only, not for human use.
-
Brief DescriptionA high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM.
-
DescriptionA high-affinity, allosteric HIV-1 and HIV-2 reverse transcriptase inhibitor (NNRTI) with EC50 of 1 nM; possesses poor oral bioavailability, and demonstrates efficacy when formulated as a topical microbicide (PC-815: Carrageenan gel formulation).HIV Infection Phase 1 Clinical
-
SynonymsPC-815;MIV150
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number231957-54-3
-
Formula Weight368.40
-
Molecular FormulaC19H17FN4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N[C@@H]1[C@H](C2=C(F)C=CC(C(CC)=O)=C2O)C1)NC3=NC=C(C#N)C=C3
-
Chemical NameN-(5-Cyano-2-pyridinyl)-N'-[(1S,2S)-2-[6-fluoro-2-hydroxy-3-(1-oxopropyl)phenyl]cyclopropyl]urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Geitmann M, et al. J Med Chem. 2006 Apr 20;49(8):2367-74.
2. Fernández-Romero JA, et al. Sex Transm Dis. 2007 Jan;34(1):9-14.
3. Singer R, et al. Sci Transl Med. 2012 Sep 5;4(150):150ra123.
2. Fernández-Romero JA, et al. Sex Transm Dis. 2007 Jan;34(1):9-14.
3. Singer R, et al. Sci Transl Med. 2012 Sep 5;4(150):150ra123.
molnova catalog
related products
-
TAT 48-57
TAT (48-57) is a cell-permeable peptide, derived from HIV-1 transactivator of transcription (Tat) protein residue 48-57.This peptide is amino acid residues 48 to 57 fragment of the basic domain of HIV Tat.
-
GSK-2838232
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
-
Fosamprenavir calciu...
A phosphate ester prodrug of the HIV-1 protease inhibitor amprenavir with improved solubility.